Back to speakers


Professor of Medicine


City: Frankfurt

Institution: JW Goethe University Hospital

Biography of Stefan ZEUZEM

Professor Zeuzem began his medical training at Goethe-University Medical School, Frankfurt Germany,. He then attended the School of Clinical Medicine at the University of Cambridge and Medical School at the University of Newcastle upon Tyne, finishing in 1985.


He completed research sabbaticals at a number of institutions, including the Howard Hughes Medical Institute, Boyer Center of Molecular Medicine at Yale University Medical School and the Max-Planck-Institute of Biophysics in Frankfurt. From 2002 to 2006 he was a full Professor of Medicine and Chairman of the Department of Internal Medicine II at Saarland University Hospital, Homburg/Saar, Germany.


Professor Zeuzem has co-authored manuscripts, book chapters and reviews encompassing varied aspects of internal medicine. He is a member of numerous professional societies including the German Association for the Study of the Liver (GASL), the European Association for the Study of the Liver (EASL) and the American Association for the Study of Liver Diseases (AASLD). He is a recipient of multiple awards and honors for his research accomplishments.


Professor Zeuzem’s clinical areas of expertise include gastroenterology, hepatology, liver transplantation, endoscopy, gastrointestinal oncology and endocrinology and his current research interests include cellular physiology, molecular biology of hepatitis viruses, viral kinetics, the role of hepatitis C in hepatocarcinogenesis, and the stratification and optimization of antiviral treatment.

PHC's participations

Monday, March 27th 2023

Worldwide overview -

Tuesday, March 09th 2021

Western Europe

13th PHC – 2020

Monday, January 13th 2020

HEPATITIS C: the elimination (chairman) -

The last difficult to treat patients -

12th PHC – 2019

Monday, January 14th 2019

HCV therapies: the last challenges -

2nd PHC – 2007

Monday, January 22nd 2007

What is the optimal treatment of naive patients with chronic hepatitis C -

Geographical Targeted Luncheons

3rd PHC – 2009

Monday, January 19th 2009

Optimizing therapy in real life illustrated with clinical cases Optimal therapy in genotype 1 patients -

4th PHC – 2011

Monday, January 17th 2011

Optimal use of virological tools -

Interactive luncheons - Room 3 (chairman)

5th PHC – 2012

Monday, January 30th 2012

Telaprevir -

6th PHC – 2013

Monday, January 14th 2013

Polymerase inhibitors -

7th PHC – 2014

Monday, January 13th 2014

Interactive luncheons - Room 1 (chairman)

New therapeutic strategies (chairman)

11th PHC – 2018

Monday, January 15th 2018

Difficult to treat patients -

10th PHC – 2017

Monday, January 30th 2017

Special populations -


8th PHC – 2015

Monday, January 12th 2015

How to optimize current therapy of non G1 patients (chairman)

9th PHC – 2016

Monday, January 11th 2016

Is it useful to detect resistance associated variants?